News & Alerts
-
Jun- 2023 -30 June
Can Ozempic and Wegovy Treat Addiction as Well as Obesity?
Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (sold under the brand names Ozempic and Wegovy by Novo Nordisk), have…
Read More » -
30 June
Key Opinion Leaders (KOLs) In The Pharmaceutical industry
In the dynamic and ever-evolving landscape of the pharmaceutical industry, Key Opinion Leaders (KOLs) play a pivotal role in shaping…
Read More » -
30 June
Fake Emails, Missed Trial Protocols, Mars BioXCel’s New Alzheimer’s Drug Path to Approval
The potential development of a new treatment for Alzheimer’s disease agitation episodes brings hope for patients and their families, as…
Read More » -
30 June
Sanofi Targets €10B in Vaccine Sales By 2030 As It Outlines Strategies
Sanofi, a prominent French pharmaceutical company, is not solely focusing on its well-known drug Dupixent. It is actively working on…
Read More » -
30 June
FDA Approves Roctavian (valoctocogene roxaparvovec-rvox) For Adults With Severe Hemophilia A
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN), a global biotechnology company dedicated to transforming lives through genetic discovery, today announced that the…
Read More » -
30 June
2 Million DEA Registrants Affected By New CME Mandate
The Consolidated Appropriations Act of 2023 introduces a new mandate that affects all physicians and healthcare providers registered with the…
Read More » -
29 June
Pediatric Growth Hormone Deficiency Drug Ngenla (somatrogon-ghla) Gets FDA Approval
Pfizer Inc and OPKO Health Inc have announced that the U.S. Food and Drug Administration (FDA) has approved Ngenla (somatrogon-ghla), a…
Read More » -
28 June
Retatrutide: The Drug That Beats Ozempic, Mounjaro, Wegovy for Weight Loss
Eli Lilly, a renowned pharmaceutical company, has unveiled an extraordinary breakthrough in weight loss treatment. Through a new study, participants…
Read More » -
27 June
These 7 Drugs Are Currently Scarce
Of the hundreds of ongoing drug shortages in the U.S., some of the most concerning cases involve lifesaving cancer medications,…
Read More » -
27 June
High-Dose Oral Semaglutide Shows Similar Efficacy as Injectable Versions – Study
The results of two Phase 3 clinical trials, OASIS and PIONEER PLUS, suggest that higher doses of oral semaglutide may…
Read More »